CME ActivitiesJDD Webinars

Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

By April 9, 2021March 23rd, 2022No Comments

JDD Multimedia

Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

Featuring Brian Berman, MD, PhD

Join JDD for Part One of this two-part webinar series on “Advancing the Understanding of Actinic Keratosis: New Treatment Options and Strategies.” In this continuing education activity, faculty will explore the pathophysiology and differential diagnosis of actinic keratosis. Dr. Berman will review understanding of therapeutic targets of AK treatment approaches.

Upon completion of this enduring, internet-based webinar, participants should be able to:

  • Review current understanding of the pathophysiology and differential diagnosis of actinic keratosis
  • Discuss therapeutic targets of actinic keratosis treatment strategies

Faculty


Brian Berman, MD, PhD
Emeritus Professor of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine, Miami, FL
Co-Director, Center for Clinical and Cosmetic Research, Miami Beach, Florida

You May Also Like

The Science of Sun Protection

| CME Activities, Dermatology Podcast Archives | No Comments
Episode 1 of a 2-Part Series: "Sun Protection: A Review of Current Interventions and Barriers to Changing Patient Attitude and Behavior" Photoprotection works, plain and simple. Yet all too often…

What’s New in Topical Treatment for Actinic Keratosis

| CME Activities, JDD Webinars | No Comments
In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor. Upon completion of this…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…

Leave a Reply